Nutriflex Peri

Amino acid blend, the active ingredient in Nutriflex Peri, is a parenteral nutrition formulation presented as a sterile solution for intravenous use. It supplies essential amino acids to support protein synthesis and metabolic needs in patients requiring nutritional support, such as those in critical care or postoperative settings.

GNH USA supplies Nutriflex Peri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution through its network.

Nutriflex Peri provides essential amino acids for parenteral nutrition in various clinical conditions.

- Post‑operative patients: supports protein synthesis and wound healing during recovery. - Severe trauma patients: supplies amino acids to counter catabolism and aid tissue repair. - Critical illness (ICU): maintains nitrogen balance and prevents muscle loss. - Burn patients: provides high‑dose amino acids to meet increased metabolic demand. - Malabsorption syndromes: delivers amino acids directly when gastrointestinal absorption is impaired. - Renal replacement therapy patients: offers controlled amino acid provision while managing nitrogen load.

Nutriflex Peri may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels, especially in diabetic patients. - Electrolyte disturbances: changes in potassium, sodium or calcium levels. - Nausea or vomiting: gastrointestinal discomfort following infusion. - Infusion site reactions: erythema, pain or phlebitis at the catheter site. - Fever or chills: transient temperature rise during administration. - Headache: mild to moderate head discomfort.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical intervention. - Metabolic acidosis: significant drop in blood pH due to acid accumulation. - Hepatic dysfunction: abnormal liver enzyme elevations indicating liver stress. - Renal failure: acute kidney injury in susceptible individuals. - Thrombophlebitis: clot formation and vein inflammation at the infusion site. - Sepsis: bloodstream infection related to catheter use.

When using Nutriflex Peri, clinicians should observe specific precautions to ensure patient safety.

- Assess renal function: adjust infusion rate in patients with impaired kidney clearance. - Monitor blood glucose: frequent checks are needed for diabetic or hyperglycemic risk. - Check electrolyte status: correct imbalances before and during therapy. - Avoid concurrent incompatible solutions: do not mix with calcium‑containing or high‑pH fluids. - Limit use in hepatic insufficiency: reduce dosage if liver function is compromised. - Store at ambient temperature: keep in original container, protect from light and moisture.

Nutriflex Peri can interact with certain medications or solutions, requiring careful management.

Major Interactions (Avoid): - Calcium‑containing solutions: may precipitate amino acids, causing catheter blockage. - High‑dose insulin: can exacerbate hypoglycemia when combined with amino acid infusion. - Renal replacement therapy fluids: may alter amino acid clearance, leading to accumulation. - Certain antibiotics (e.g., aminoglycosides): increased risk of nephrotoxicity when given concurrently. - Vasopressors: may affect peripheral circulation and infusion site integrity.

Moderate Interactions (Monitor Closely): - Loop diuretics: can intensify electrolyte shifts, requiring monitoring. - Steroids: may increase protein catabolism, influencing amino acid needs. - Anticonvulsants (e.g., phenobarbital): may affect amino acid metabolism. - Heparin lock solutions: potential for additive anticoagulant effect. - Parenteral lipid emulsions: co‑administration may require timing adjustments to avoid incompatibility.